Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SKT | Ann: Sky ASM and Closing Date for Director Nominations | 06:50 | 0 | 56 | |||
|
|||||||
SKT | Ann: Sky Announces Full Year Result | 21/08/24 | 0 | 70 | |||
|
|||||||
SKT | Ann: Sky provides update on status of satellite supply | 19/08/24 | 0 | 63 | |||
|
|||||||
SKT | Ann: FY24 Annual Results - announcement date | 22/07/24 | 0 | 98 | |||
|
|||||||
SKT | Ann: Change in ASX Listing Status | 18/07/24 | 0 | 64 | |||
|
|||||||
SKT | Ann: SPH Notice - New Zealand Superannuation Fund Nominees Ltd | 26/06/24 | 0 | 83 | |||
|
|||||||
SKT | Ann: SPH Notice - New Zealand Superannuation Fund Nominees Ltd | 11/06/24 | 0 | 112 | |||
|
|||||||
SKT | Ann: Sky pauses Share Buyback for full-year results black out | 06:50 | 0 | 129 | |||
|
See All Discussions